A study to calculate the efficacy of panchavalkal kwath Prakshalan followed by shatadhauta ghrut ointment application versus panchavalkal kwath Prakshalan only in the management of Napkin Rash.

A RANDOMISED COMPARATIVE CLINICAL TRIAL TO STUDY THE EFFICACY OF PANCHAVALKAL KWATH PRAKSHALAN FOLLOWED BY SHATADHAUTA GHRUT OINTMENT VS PANCHAVALKAL KWATH PRAKSHALAN ALONE IN THE MANAGEMENT OF AHIPUTANA (NAPKIN RASH) IN INFANTS - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108064

Enrollment

Registered

2026-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Infants aged 1 to 12 months of either sex.2)Clinical diagnosis of Ahiputana (napkin rash) of at least Grade 1 severity (mild erythema) but not exceeding Grade 3 (early ulceration). 3)Rash localized to the diaper area (perineum, buttocks, groin).4)Onset of rash within the last 7 days.5)Parental/guardian written informed consent to participate.6)Willingness to comply with study procedures and follow-up visits.

Exclusion criteria

Exclusion criteria: 1) Evidence of secondary bacterial or fungal infection 2)Use of topical steroids, systematic antibiotics,or antifungal over rash area in last 14 days 3)known allergy or hypersensitivity to any components of panchavalkal kwath or shatadhauta ghruta 4)infants born preterm or with low birth weight 5) congenital skin disorders or chronic dermatologic disease over diaper area 6) significant systemic illness or immunodeficiency 7) Participation in another clinical trial within last 30 days

Design outcomes

Primary

Measure	Time frame
Complete ReliefTimepoint: 14 Days	—

Secondary

Measure	Time frame
Marked reliefTimepoint: 14 days follow up;Moderate ReliefTimepoint: 14 days follow up;Mild reliefTimepoint: 14 days follow up;No relief less than 25 percentTimepoint: 14 days follow up;No improvementTimepoint: 14 days follow up	—

Countries

India

Contacts

Public ContactDr Monal Bhiwgade

Shri Babu Singh Jay Singh Ayurvedic Medical College And Hospital Farrukhabad, Uttarpradesh

dr.vkswami@gmail.com9928427025

Outcome results